Anti-drug awareness programme held
Speaking on the occasion, G Archana, Deputy Director, Department of Welfare of Differently Abled, Transgender and Senior Citizens (Anantapur & Sri Sathya Sai districts), urged the youth to set clear goals and move forward with discipline.
She emphasised that since 2020, the State government has been taking determined measures to curb drug abuse and organising awareness drives in coordination with the medical, police and excise departments.
Archana warned that possession, sale, storage, or transportation of narcotic substances is a criminal offence, punishable with up to 10 years of imprisonment.
She highlighted the devastating impact of drug addiction on young lives, leading to social and economic downfall. Parents, she said, make significant sacrifices to educate their children, and youth should not ruin their future through substance abuse.
She informed that those addicted to drugs are referred to the government de-addiction centre at Hindupur District Hospital or private facilities like Swear De-addiction Centre for treatment and counselling. Citizens can report drug-related incidents to the Eagle toll-free helpline 1972.
The programme concluded with a pledge administered to students against drug abuse and illegal trafficking under the International Day Against Drug Abuse framework. College Principal, staff, and departmental officials participated in the event.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
a day ago
- Hans India
MBNR ASI honoured with Indian Police Medal
Mahabubnagar: Assistant Sub-Inspector (ASI) Mohammed Moizuddin from Mahabubnagar has been awarded the Indian Police Medal (IPM) by the Government of India on the occasion of the 79th Independence Day. Joining the force in 1989 as a young Police Constable, Moizuddin's career has been marked by dedication and discipline. Over the years, he has served in several key police stations including Alampur, Thimmajipet, Jadcherla, Peddakothapally, and Kosgi. His commitment earned him a promotion to Head Constable in 2012, followed by his elevation to ASI in 2018. Since then, he has worked in the CCS Mahabubnagar, Hanwada, and Traffic Police Station, and is currently posted at Koilkonda Police Station. Moizuddin's career speaks for itself—70 cash rewards, 18 GSEs, 12 appreciation certificates, a Seva Medal (2013), the Telangana Chief Minister's Distinguished Police Medal (2017), and the Uttak Police Medal (2019). Congratulating him on the honour, Mahabubnagar District SP D Janaki, said, 'His discipline, dedication, and unwavering commitment to public service are truly commendable. This award is a fitting tribute to his remarkable contribution to the police department.'
Time of India
a day ago
- Time of India
Two arrested in 2010-11 Minority Pre-Matric Scholarship scam
Lucknow: The Economic Offences Wing (EOW) team on Thursday arrested two individuals from Meerut in connection with the embezzlement of Rs 4 crore, earmarked for the Minority Pre-Matric Scholarship during the 2010-11 fiscal year. The accused — Dharmapal Singh alias Brahmpal and Mohsina Khan — were booked under IPC sections of 409, 420, 467, 468, 471, 120B of the Indian Penal Code, along with section 8 of the Prevention of Corruption Act. The Minority Pre-Matric Scholarship, provided by the Government of India, was intended to support minority students. However, it is alleged that the funds were misappropriated by school and madrasa administrators, headmasters, and managers, in collusion with the then district minority welfare officer of Meerut and others. The investigation into these allegations is being conducted by the EOW, Meerut sector. Dharmapal, manager of Nav Shishu Vidya Mandir, Nihori, Meerut, and Mohsina, manager of Mohsina Islamic Madrasa, Zakir Colony, Meerut, were wanted in these cases. They allegedly embezzled the scholarship funds provided by the Government of India, causing significant financial loss to the state. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area. Get the latest lifestyle updates on Times of India, along with Happy Independence Day wishes , messages , and quotes !
NDTV
2 days ago
- NDTV
Global First: Indian Scientists Map Cervical Cancer At Molecular Level, Open Doors To Precision Treatment
In a landmark achievement that places India firmly on the global oncology map, a team of Indian scientists and clinicians has conducted the country's first-ever integrative genomic and phosphoproteomic analysis of cervical cancer. This pioneering research, based on patient samples from Bihar, a state heavily impacted by the disease, unravels why some patients fail to respond to standard treatments and suggests more effective, personalised alternatives. Led by PhD scholars Janani Sambath and Irene A. George under the mentorship of Dr. Prashant Kumar, this study represents the world's first whole-genome and global proteomics-phosphoproteomics mapping of cervical cancer. On the clinical front, Dr. Richa Chauhan, senior oncologist at Mahavir Cancer Sansthan, Patna, monitored the application of these findings in real-world scenarios. "This research is close to my heart," says Dr. Chauhan. "As a cancer physician, I see women every day, many from rural or underserved backgrounds, with late-stage cervical cancer. Being part of a study that not only decodes resistance but also proposes actionable solutions is deeply gratifying." Revealing The Genetic Drivers Of Resistance Using advanced DNA sequencing, the researchers identified two major genetic alterations common in treatment-resistant cervical tumours: An increase in the number of copies of the EGFR gene, which accelerates cancer cell growth and spread. The loss of the STK11 gene, which normally functions as a growth brake. These findings are clinically significant as EGFR can be targeted using existing cancer drugs, potentially offering life-saving treatment options for patients unresponsive to standard therapy. Proteins That Hold The Key The proteomics arm of the study revealed that the CSNK2A1 protein acts as a "master switch" in treatment-resistant tumours, enabling survival pathways. Blocking this protein with the drug silmitasertib, in combination with low-dose cisplatin, significantly reduced cancer growth in lab experiments. In parallel, the phosphoproteomics analysis uncovered another protein-STX3-consistently present at high levels in resistant tumours. Identified as a powerful biomarker, STX3's discovery has been patented by the Government of India (Patent No. 404113) and has garnered widespread national attention. Recognition On The Global Stage Dr. Prashant Kumar presented the study at the ESMO Asia Congress 2024 in Singapore, where it earned the prestigious Best Poster Award, competing against top cancer research teams worldwide. This recognition not only validates the scientific excellence of the work but also strengthens India's position in the fight against women's cancers. "This is not just a scientific achievement, it's a social imperative," says Dr. Kumar. "We're proud that our research, powered by Indian samples and minds, is creating real translational possibilities." Why It Matters For India: Cervical Cancer Impact On Indian Women Cervical cancer is the second most common cancer among Indian women, responsible for nearly 10% of all female cancer cases. Despite HPV vaccination efforts, rural states like Bihar continue to face late-stage diagnoses, underscoring the urgent need for early detection tools and improved treatment protocols. Cervical cancer begins in the cervix-the lower part of the uterus-and is typically driven by long-term infection with high-risk human papillomavirus (HPV) types, especially HPV-16 and 18. Often slow to show symptoms, it may initially involve irregular or abnormal vaginal bleeding, making regular screening (via Pap smears or HPV tests) vital for early detection and successful treatment. Globally, it ranks as the fourth most common cancer in women, with over 600,000 new cases and nearly 342,000 deaths reported in 2020. In India, the burden is even higher: age-standardised incidence is about 14.7 per 100,000 women, with a mortality rate of 9.2 per 100,000, as another study published in BMC Cancer in 2022 suggests. Roughly 96,900 new cases are diagnosed annually, with 60,000-67,000 deaths, accounting for about one-fifth of global cervical cancer burden. The five-year survival rate in India hovers around 47%, significantly lower than figures in more developed countries. Vulnerable groups, such as women from lower socioeconomic strata, rural areas, and with limited education, are disproportionately affected. Incidence rates peak among women aged 50-59, especially in regions like Northeast India, with cities like Aizawl reporting rates as high as 24 per 100,000. Alarmingly, screening rates remain abysmally low. Data from NFHS-5 shows only about 1-2% of women have ever undergone cervical cancer screening. This wide gap in awareness and access underscores a pressing public health priority. Keeping these in mind, the team behind the new breakthrough study aims to move silmitasertib-based combination regimens into clinical trials, alongside the development of targeted clinical tests to guide treatment planning. With its blend of cutting-edge molecular science and deep compassion for patients, this research offers renewed hope to thousands of women who need it most.
